Skip to content

Should pre-procedure oral vitamin C supplementation be considered in people with diabetes undergoing dental procedures?

Should pre-procedure oral vitamin C supplementation be considered in people with diabetes undergoing dental procedures? An observational study into vitamin C levels of people with and without diabetes undergoing dental extraction

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12623001182684
Enrollment
60
Registered
2023-11-15
Start date
2023-11-20
Completion date
2025-03-28
Last updated
2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This is a feasibility study with the aim of measuring the vitamin C status of people undergoing either a full or partial dental clearance. We will obtain data from 30 people with diabetes (PwD) and 30 people without diabetes who have been referred to the hospital outpatient dental department. Our primary objective is to determine the percentage of people undergoing dental clearance who are vitamin C deficient. We hypothesise that PwD will show evidence of hypovitaminosis C, though a smaller number of people without diabetes may also have low vitamin C levels.

Interventions

Surgical dental extraction. Fasting blood and urine collection on one occasion to measure paired vitamin C level. The collection of fasting samples will be at the patient's choice - either 1-2 days prior to the extraction appointment, or on the day of the procedure. They will be given food after the fasting samples have been collected. Participants will be asked to complete a health related questionnaire during their extraction appointment.

Sponsors

Te Whatu Ora - Waitaha Canterbury
Lead SponsorHospital

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

People attending the hospital outpatient dental department for full and partial dental extractions (both groups) - Able to understand study and give full and informed consent - Agree to collection of age, ethnicity and health data - Willing / able to give a fasting blood and urine sample Group of 30 people without diabetes - HbA1c below 53 mmol/mol (7%) - not on any diabetes related medication - such as insulin, metformin, sulphonylurea's, DPPIV inhibitors, GLP1 receptor agonists or SGLT2 inhibitors Group of 30 people with diabetes - HbA1c of 53 mmol/mol (7%) or greater

Exclusion criteria

For both groups of participants: - Unable to fast prior to the sample collection - Unable to understand the informed consent or study requirements - Unwilling to participate

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026